Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

EPA weighs petition for new rules to limit pesticide labeling litigation, preempt state-level requirements | Agri-Pulse Communications, Inc.

Bayer eyes bigger role in China's agri-tech innovation, products - Chinadaily.com.cn

Case: Patents/Summary Judgment (E.D. Mo.)

Court Certifies National Class Action Against Monsanto and Bayer Over Alleged Link Between Roundup® and Non-Hodgkin's Lymphoma
Therapeutic Nuclear Drugs Market Report 2025: Strategic Partnerships Propel Innovation with Global Revenues Reaching $3.86 Billion by 2029 at 14.7% CAGR

Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results

Pet Vaccine Market Trends Show Increased Demand for Canine and Feline Vaccines Across North America Europe and Asia Pacific

Bayer (BAYRY) Secures FDA Orphan Status for Whipworm Infection Drug | BAYRY Stock News

BlueRock Therapeutics Announces Publication in Nature of 18-Month Data from Phase 1 Clinical Trial for Bemdaneprocel, an Investigational Cell Therapy for Parkinson's Disease

Bayer CEO says firm may stop making Roundup

Arrowhead Pharmaceuticals Announces CFO Transition | ARWR stock news

Bayer to invest more in health, nutrition sector - Chinadaily.com.cn

Lanxess optimistic about 10% income growth in 2025 - Chinadaily.com.cn

Bayer (BAYZF) Considers Halting Roundup Production Amid Legal Challenges

Novo Nordisk, Bayer, GSK among giants accused in drug delivery suits
Bayer Leverkusen CEO confident Wirtz and Alonso will stay beyond summer - Yahoo Sports

Sports & Performance Nutrition Drinks Market Poised for Rapid Expansion as Athletes and Consumers Seek Targeted Functional Beverages

Bayer, J&J Defeat Whistleblower's Bid to Reinstate Fraud Suit

U.S. FDA Grants Full Approval of Vitrakvi (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive Solid Tumors

Bayer & Iberdrola: A World First in Total Decarbonisation | Sustainability Magazine

European pharma companies warn Trump's tariffs could expedite shift to US

Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis
Bayer asks Supreme Court to intervene in Roundup cancer claim lawsuits

US to impose 104pc tariff on all Chinese goods from tomorrow morning

AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors | The Manila Times

Bayer Poised for Breakthrough Year in Pharmaceuticals

Bayer petitions Supreme Court to dismiss Roundup cases - Brownfield Ag News
Scar Management Market Forecast 2025-2035: Silicone-Based Products and Atrophic Scar Treatments Lead Global Scar Management Trends

Bayer to issue carbon credits generated by rice farmers in India

Bayer eyes launch of menopause relief, heart drugs this year

Bayer (BAYZF) Seeks U.S. Supreme Court Review in Roundup Litigation

Bayer renews bid for US Supreme Court to curb glyphosate cases
Bayer to launch groundbreaking products with blockbuster potential in 2025

Bayer Pharmaceuticals poised for landmark year

Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States

Bayer asks high court to take $1.25 million Roundup appeal | News & Features | ArcaMax Publishing

Bayer asks high court to take $1.25 million Roundup appeal | Political News | ArcaMax Publishing

New fungicide hits the market for wheat

Mid North farmers update with latest cropping insights

Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor VVD-159642 for Treatment of Advanced Solid Tumors

French parents sue Bayer over glyphosate birth defects in their son
:max_bytes(150000):strip_icc()/IMG_8440-2048x1365-cef1453d7a3c4f178f582c89f86ef3d8.jpg)
Representative: Lawmakers Have 'Concerns' on Pesticide Immunity Bill

Sustainable Agriculture Market to Benefit from Rising Awareness and Corporate Sustainability Programs

Bayer Pharma to expand cardiology, women's health portfolios with new drugs this year - Healthcare News | The Financial Express

Bayer to issue first carbon credits from regenerative farming practices in India | Valuespectrum.com

Two-year nighttime blood pressure changes after radiofrequency renal denervation: pooled results from the SPYRAL HTN trials

Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript

'Always new twists': Bayer legal team on defending a $4bn drug

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism

Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial

Bayer ordered to pay $2.1 billion in Roundup cancer lawsuit

Asian rise: AI-driven transformation, digital economies, path to net-zero

Times NOW Asian Business Leaders Conclave 2025 explores AI-driven transformation, digital economies, path to net-zero, ET Government

Hybrid Seeds Market Growth From USD 24.14 Billion in 2022 to an 11.0% CAGR by 2032 | Taiwan News | Mar. 27, 2025 06:02

Expanding access to dialysis coverage in Mexico

Farmer Benefits of Planting DEKALB® Brand Products - Brownfield Ag News

DAX Moderately Lower In Cautious Trade

Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK

Research articles | Nature Communications

Bayer loses Georgia Roundup case

Business NewsLine, March 25, 2025

ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes | Morningstar

DAX Advances On Positive Business Data

Doritos Crash The Super Bowl; Carat on Culture Measurement; Assembly on Authenticity; HubSpot on AI's Agility; Bayer on Engaging Social Video 03/25/2025

Bayer hit with $3.3b Roundup verdict in US cancer case

Bayer told to pay almost $2.1bn over Roundup cancer link claim

Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
Latest news

Commodity market today: Crude Oil Fluctuates as OPEC+ Modifies Production Goals

Morning Note: Trump Calms Fed Fears; Tesla Disappoints; UK Trade Talks Begin

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Gold Price Today: XAU/USD Over $3,350 on Trump's Tariff Policies Uncertainty